Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 2000 May 16;162(10):1415–1420.

Treatment and outcomes of community-acquired pneumonia at Canadian hospitals

B G Feagan 1, T J Marrie 1, C Y Lau 1, S L Wheeler 1, C J Wong 1, M K Vandervoort 1
PMCID: PMC1232453  PMID: 10834044

Abstract

BACKGROUND: Community-acquired pneumonia is a common disease with a large economic burden. We assessed clinical practices and outcomes among patients with community-acquired pneumonia admitted to Canadian hospitals. METHODS: A total of 20 hospitals (11 teaching and 9 community) participated. Data from the charts of adults admitted during November 1996, January 1997 and March 1997 were reviewed to determine length of stay (LOS), admission to an intensive care unit and 30-day in-hospital mortality. Multivariate analyses examined sources of variability in LOS. The type and duration of antibiotic therapy and the proportion of patients who were treated according to clinical practice guidelines were determined. RESULTS: A total of 858 eligible patients were identified; their mean age was 69.4 (standard deviation 17.7) years. The overall median LOS was 7.0 days (interquartile range [IQR] 4.0-11.0 days); the median LOS ranged from 5.0 to 9.0 days across hospitals (IQR 6.0-7.8 days). Only 22% of the variability in LOS could be explained by known factors (disease severity 12%; presence of chronic obstructive lung disease or bacterial cause for the pneumonia 2%; hospital site 7%). The overall 30-day mortality was 14.1% (95% confidence interval [CI] 11.8%-16.6%); 13.6% of the patients were admitted to an intensive care unit (95% CI 11.4%-16.1%). The median duration of intravenous antibiotic therapy was 5 days (range 3.0-6.5 days across hospitals). Although 79.8% of patients received treatment according to clinical practice guidelines, the rate of compliance with the guidelines ranged from 47.9% to 100% across hospitals. INTERPRETATION: Considerable heterogeneity exists in the management of community-acquired pneumonia at Canadian hospitals, the causes of which are poorly understood.

Full Text

The Full Text of this article is available as a PDF (238.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atlas S. J., Benzer T. I., Borowsky L. H., Chang Y., Burnham D. C., Metlay J. P., Halm E. A., Singer D. E. Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial. Arch Intern Med. 1998 Jun 22;158(12):1350–1356. doi: 10.1001/archinte.158.12.1350. [DOI] [PubMed] [Google Scholar]
  2. Bartlett J. G., Breiman R. F., Mandell L. A., File T. M., Jr Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America. Clin Infect Dis. 1998 Apr;26(4):811–838. doi: 10.1086/513953. [DOI] [PubMed] [Google Scholar]
  3. Bartlett J. G., Mundy L. M. Community-acquired pneumonia. N Engl J Med. 1995 Dec 14;333(24):1618–1624. doi: 10.1056/NEJM199512143332408. [DOI] [PubMed] [Google Scholar]
  4. Cleary P. D., Greenfield S., Mulley A. G., Pauker S. G., Schroeder S. A., Wexler L., McNeil B. J. Variations in length of stay and outcomes for six medical and surgical conditions in Massachusetts and California. JAMA. 1991 Jul 3;266(1):73–79. [PubMed] [Google Scholar]
  5. Fine M. J., Auble T. E., Yealy D. M., Hanusa B. H., Weissfeld L. A., Singer D. E., Coley C. M., Marrie T. J., Kapoor W. N. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997 Jan 23;336(4):243–250. doi: 10.1056/NEJM199701233360402. [DOI] [PubMed] [Google Scholar]
  6. Fine M. J., Hough L. J., Medsger A. R., Li Y. H., Ricci E. M., Singer D. E., Marrie T. J., Coley C. M., Walsh M. B., Karpf M. The hospital admission decision for patients with community-acquired pneumonia. Results from the pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med. 1997 Jan 13;157(1):36–44. [PubMed] [Google Scholar]
  7. Fine M. J., Medsger A. R., Stone R. A., Marrie T. J., Coley C. M., Singer D. E., Akkad H., Hough L. J., Lang W., Ricci E. M. The hospital discharge decision for patients with community-acquired pneumonia. Results from the Pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med. 1997 Jan 13;157(1):47–56. [PubMed] [Google Scholar]
  8. Fine M. J., Singer D. E., Phelps A. L., Hanusa B. H., Kapoor W. N. Differences in length of hospital stay in patients with community-acquired pneumonia: a prospective four-hospital study. Med Care. 1993 Apr;31(4):371–380. doi: 10.1097/00005650-199304000-00008. [DOI] [PubMed] [Google Scholar]
  9. Gilbert K., Gleason P. P., Singer D. E., Marrie T. J., Coley C. M., Obrosky D. S., Lave J. R., Kapoor W. N., Fine M. J. Variations in antimicrobial use and cost in more than 2,000 patients with community-acquired pneumonia. Am J Med. 1998 Jan;104(1):17–27. doi: 10.1016/s0002-9343(97)00274-x. [DOI] [PubMed] [Google Scholar]
  10. Guest J. F., Morris A. Community-acquired pneumonia: the annual cost to the National Health Service in the UK. Eur Respir J. 1997 Jul;10(7):1530–1534. doi: 10.1183/09031936.97.10071530. [DOI] [PubMed] [Google Scholar]
  11. Marras T. K., Chan C. K. Use of guidelines in treating community-acquired pneumonia. Chest. 1998 Jun;113(6):1689–1694. doi: 10.1378/chest.113.6.1689. [DOI] [PubMed] [Google Scholar]
  12. Marrie T. J., Lau C. Y., Wheeler S. L., Wong C. J., Vandervoort M. K., Feagan B. G. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA. 2000 Feb 9;283(6):749–755. doi: 10.1001/jama.283.6.749. [DOI] [PubMed] [Google Scholar]
  13. McCormick D., Fine M. J., Coley C. M., Marrie T. J., Lave J. R., Obrosky D. S., Kapoor W. N., Singer D. E. Variation in length of hospital stay in patients with community-acquired pneumonia: are shorter stays associated with worse medical outcomes? Am J Med. 1999 Jul;107(1):5–12. doi: 10.1016/s0002-9343(99)00158-8. [DOI] [PubMed] [Google Scholar]
  14. Niederman M. S., McCombs J. S., Unger A. N., Kumar A., Popovian R. The cost of treating community-acquired pneumonia. Clin Ther. 1998 Jul-Aug;20(4):820–837. doi: 10.1016/s0149-2918(98)80144-6. [DOI] [PubMed] [Google Scholar]
  15. Weingarten S. R., Riedinger M. S., Varis G., Noah M. S., Belman M. J., Meyer R. D., Ellrodt A. G. Identification of low-risk hospitalized patients with pneumonia. Implications for early conversion to oral antimicrobial therapy. Chest. 1994 Apr;105(4):1109–1115. doi: 10.1378/chest.105.4.1109. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES